Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Certifies First Center of Excellence

NEW YORK (GenomeWeb News) – Sequenom and Genome Quebec announced today that Sequenom has certified its first Center of Excellence for genotyping technology: the McGill University and Genome Quebec Innovation Centre.

Under the new collaboration, the Innovation Centre, which is funded by Genome Canada and the Quebec provincial government, plans to use the Sequenom MassARRAY system to help maintain high-quality genotyping data. It currently has two MassARRAY compact instruments and plans to begin testing for qualification of Sequenom’s EpiTYPER methylation services in the near future.

The institution will be the only Sequenom Genotyping Center of Excellence in Canada for the first year of its certification, though Sequenom has indicated that it eventually hopes to expand the certification program to other academic and research institutions. To receive the certification, Genome Quebec passed initial laboratory qualification and proficiency tests and operating procedure audits that looked at criteria such as data delivery and turnaround time.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.